| RS121912642 |
LHX4
|
Health Risk |
Conflicting classifications of pathogenicity |
Short stature-pituitary and cerebellar defects-small sella turcica syndrome, Short stature-pituitary and cerebellar defects-small sella turcica syndrome |
| RS121912643 |
LHX4
|
Health Risk |
Pathogenic |
Short stature-pituitary and cerebellar defects-small sella turcica syndrome, Short stature-pituitary and cerebellar defects-small sella turcica syndrome |
| RS121912644 |
LHX4
|
Health Risk |
Pathogenic |
Short stature-pituitary and cerebellar defects-small sella turcica syndrome, Short stature-pituitary and cerebellar defects-small sella turcica syndrome |
| RS121912645 |
KLF11
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 7, Maturity-onset diabetes of the young type 7 |
| RS121912646 |
TG
|
Health Risk |
Pathogenic |
Iodotyrosyl coupling defect, Congenital hypothyroidism |
| RS121912647 |
TG
|
Health Risk |
Pathogenic |
Iodotyrosyl coupling defect, Iodotyrosyl coupling defect |
| RS121912648 |
TG
|
Health Risk |
Pathogenic |
Iodotyrosyl coupling defect, Congenital hypothyroidism |
| RS121912650 |
TG
|
Health Risk |
Likely pathogenic |
Iodotyrosyl coupling defect, Autoimmune thyroid disease |
| RS121912651 |
TP53
|
Health Risk |
Pathogenic/Likely pathogenic |
Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome |
| RS121912652 |
TP53
|
Health Risk |
Pathogenic |
Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome |
| RS121912653 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome 1, Li-Fraumeni syndrome |
| RS121912654 |
TP53
|
Health Risk |
Pathogenic/Likely pathogenic |
Hepatocellular carcinoma, Hereditary cancer-predisposing syndrome |
| RS121912655 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-fraumeni-like syndrome, Hereditary cancer-predisposing syndrome |
| RS121912656 |
TP53
|
Health Risk |
Pathogenic |
Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome |
| RS121912657 |
TP53
|
Health Risk |
Pathogenic |
Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome |
| RS121912658 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-fraumeni-like syndrome, Hereditary cancer-predisposing syndrome |
| RS121912659 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial colorectal cancer, Non-Hodgkin lymphoma |
| RS121912660 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Nasopharyngeal carcinoma, Li-Fraumeni syndrome |
| RS121912662 |
TP53
|
Health Risk |
Likely pathogenic |
Li-Fraumeni syndrome 1, Li-Fraumeni syndrome |
| RS121912663 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, 12 conditions |
| RS121912664 |
TP53
|
Health Risk |
Likely pathogenic |
ADRENOCORTICAL CARCINOMA, PEDIATRIC |
| RS121912665 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial colorectal cancer, Hereditary cancer-predisposing syndrome |
| RS121912666 |
TP53
|
Health Risk |
Pathogenic |
Li-Fraumeni syndrome 1, Li-Fraumeni syndrome |
| RS121912667 |
TP53
|
Health Risk |
Pathogenic |
ADRENOCORTICAL CARCINOMA, PEDIATRIC |
| RS121912668 |
SLC5A1
|
Health Risk |
Likely pathogenic |
Congenital glucose-galactose malabsorption, Congenital glucose-galactose malabsorption |
| RS121912670 |
CHRNG
|
Health Risk |
Pathogenic |
Autosomal recessive multiple pterygium syndrome, Lethal multiple pterygium syndrome |
| RS121912671 |
CHRNG
|
Health Risk |
Likely pathogenic |
Autosomal recessive multiple pterygium syndrome, Lethal multiple pterygium syndrome |
| RS121912672 |
CHRNG
|
Health Risk |
Pathogenic |
Autosomal recessive multiple pterygium syndrome, Lethal multiple pterygium syndrome |
| RS121912673 |
ACTC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1R, Hypertrophic cardiomyopathy 11 |
| RS121912674 |
ACTC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1R, Atrial septal defect 5 |
| RS121912675 |
ACTC1
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 11, Atrial septal defect 5 |
| RS121912676 |
ACTC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 11, Atrial septal defect 5 |
| RS121912677 |
ACTC1
|
Health Risk |
Pathogenic |
Atrial septal defect 5, Atrial septal defect 5 |
| RS121912678 |
ACVR1
|
Health Risk |
Pathogenic |
Progressive myositis ossificans, Inborn genetic diseases |
| RS121912679 |
ACVR1
|
Health Risk |
Pathogenic |
Progressive myositis ossificans, Diffuse midline glioma |
| RS121912680 |
ACVR1
|
Health Risk |
Pathogenic |
Progressive myositis ossificans, Progressive myositis ossificans |
| RS121912681 |
APRT
|
Health Risk |
Pathogenic/Likely pathogenic |
Adenine phosphoribosyltransferase deficiency, See cases |
| RS121912682 |
AMPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscle AMP deaminase deficiency, Muscle AMP deaminase deficiency |
| RS121912683 |
SLC25A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive |
| RS121912685 |
AFP
|
Health Risk |
Pathogenic |
Alpha-fetoprotein deficiency, Alpha-fetoprotein deficiency |
| RS121912691 |
SLC3A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystinuria, See cases |
| RS121912693 |
SLC3A1
|
Health Risk |
Likely pathogenic |
Cystinuria, Cystinuria |
| RS121912694 |
SLC3A1
|
Health Risk |
Pathogenic |
Cystinuria, Cystinuria |
| RS121912698 |
ACY1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aminoacylase 1 deficiency, Inborn genetic diseases |
| RS121912699 |
ACY1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aminoacylase 1 deficiency, Inborn genetic diseases |
| RS121912700 |
ACY1
|
Health Risk |
Pathogenic |
Aminoacylase 1 deficiency, Aminoacylase 1 deficiency |
| RS121912702 |
AGT
|
Health Risk |
Pathogenic |
Renal tubular dysgenesis, Renal tubular dysgenesis |
| RS121912704 |
ACE
|
Health Risk |
Likely pathogenic |
Renal tubular dysgenesis, Microvascular complications of diabetes |
| RS121912705 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrhythmia, ankyrin-B-related |
| RS121912706 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 4, Death in infancy |
| RS121912707 |
ALDH7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyridoxine-dependent epilepsy, Seizure |
| RS121912708 |
ALDH7A1
|
Health Risk |
Likely pathogenic |
Pyridoxine-dependent epilepsy, Seizure |
| RS121912709 |
ALDH7A1
|
Health Risk |
Pathogenic |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS121912710 |
ALDH7A1
|
Health Risk |
Pathogenic |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS121912711 |
ALDH7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS121912712 |
SERPINA1
|
Health Risk |
Conflicting classifications of pathogenicity |
PI CHRISTCHURCH, Alpha-1-antitrypsin deficiency |
| RS121912713 |
SERPINA1
|
Health Risk |
Pathogenic |
Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation, Alpha-1-antitrypsin deficiency |
| RS121912714 |
SERPINA1
|
Health Risk |
Pathogenic; other |
PI NULL(CARDIFF), PI P(DUARTE) |
| RS121912715 |
IFNGR1
|
Health Risk |
Pathogenic |
Immunodeficiency 27A, Immunodeficiency 27A |
| RS121912716 |
APOA1
|
Health Risk |
Pathogenic |
APOLIPOPROTEIN A-I (MARBURG), APOLIPOPROTEIN A-I (MARBURG) |
| RS121912718 |
APOA1
|
Health Risk |
Pathogenic |
Hypoalphalipoproteinemia, primary |
| RS121912720 |
APOA1
|
Health Risk |
Pathogenic |
APOLIPOPROTEIN A-I (MUNSTER3C), APOLIPOPROTEIN A-I (MUNSTER3C) |
| RS121912723 |
APOA1
|
Health Risk |
Pathogenic |
Hypoalphalipoproteinemia, primary |
| RS121912724 |
APOA1
|
Health Risk |
Pathogenic |
Familial amyloid polyneuropathy, Iowa type |
| RS121912725 |
APOA1
|
Health Risk |
Pathogenic |
Hypoalphalipoproteinemia, primary |
| RS121912726 |
APOA1
|
Health Risk |
Pathogenic |
Familial amyloid polyneuropathy, Iowa type |
| RS121912727 |
APOA1
|
Health Risk |
Pathogenic |
Hypoalphalipoproteinemia, primary |
| RS121912728 |
APOA1
|
Health Risk |
Pathogenic |
— |
| RS121912729 |
APOA1
|
Health Risk |
Pathogenic |
Familial amyloid polyneuropathy, Iowa type |
| RS121912730 |
APOA1
|
Health Risk |
Pathogenic |
Familial amyloid polyneuropathy, Iowa type |
| RS121912731 |
ATP2A2
|
Health Risk |
Pathogenic |
Keratosis follicularis, Keratosis follicularis |
| RS121912732 |
ATP2A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Darier disease, acral hemorrhagic type |
| RS121912733 |
ATP2A2
|
Health Risk |
Pathogenic |
Darier disease, acral hemorrhagic type |
| RS121912734 |
ATP2A2
|
Health Risk |
Pathogenic |
Keratosis follicularis, Keratosis follicularis |
| RS121912735 |
ATP2A2
|
Health Risk |
Pathogenic |
Darier disease, segmental |
| RS121912736 |
ATP2A2
|
Health Risk |
Pathogenic |
Darier disease, segmental |
| RS121912737 |
ATP2A2
|
Health Risk |
Pathogenic |
Acrokeratosis verruciformis of Hopf, Acrokeratosis verruciformis of Hopf |
| RS121912738 |
ATP2A2
|
Health Risk |
Pathogenic |
Keratosis follicularis, Keratosis follicularis |
| RS121912739 |
NPR2
|
Health Risk |
Pathogenic |
Acromesomelic dysplasia 1, Maroteaux type |
| RS121912741 |
SLC4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 4, Hereditary spherocytosis type 4 |
| RS121912742 |
SLC4A1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 4, Hereditary spherocytosis type 4 |
| RS121912744 |
SLC4A1
|
Health Risk |
Pathogenic |
Autosomal dominant distal renal tubular acidosis, Distal renal tubular acidosis |
| RS121912745 |
SLC4A1
|
Health Risk |
Likely pathogenic |
Autosomal dominant distal renal tubular acidosis, 11 conditions |
| RS121912746 |
SLC4A1
|
Health Risk |
Pathogenic |
Autosomal dominant distal renal tubular acidosis, Autosomal dominant distal renal tubular acidosis |
| RS121912748 |
SLC4A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal tubular acidosis, distal |
| RS121912749 |
SLC4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 4, Autosomal dominant distal renal tubular acidosis |
| RS121912750 |
SLC4A1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 4, Hereditary spherocytosis type 4 |
| RS121912751 |
SLC4A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant distal renal tubular acidosis, Renal tubular acidosis |
| RS121912752 |
SLC4A1
|
Health Risk |
Pathogenic |
Renal tubular acidosis, distal |
| RS121912753 |
SLC4A1
|
Health Risk |
Pathogenic |
Renal tubular acidosis, distal |
| RS121912754 |
SLC4A1
|
Health Risk |
Pathogenic |
Renal tubular acidosis, distal |
| RS121912755 |
SLC4A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spherocytosis type 4, 11 conditions |
| RS121912757 |
SLC4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
SWANN BLOOD GROUP ANTIGEN, Autosomal dominant distal renal tubular acidosis |
| RS121912759 |
SLC4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Acanthocytosis due to band 3 HT, Acanthocytosis |
| RS121912767 |
BMP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Orofacial cleft 11, Microphthalmia with brain and digit anomalies |
| RS121912769 |
COL17A1
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa, Epidermolysis bullosa |
| RS121912770 |
COL17A1
|
Health Risk |
Pathogenic |
Epidermolysis bullosa, junctional 4 |
| RS121912771 |
COL17A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Epithelial recurrent erosion dystrophy, Epidermolysis bullosa |
| RS121912772 |
COL17A1
|
Health Risk |
Pathogenic |
Epidermolysis bullosa, junctional 4 |
| RS121912773 |
COL17A1
|
Health Risk |
Pathogenic |
Epidermolysis bullosa, junctional 4 |